Nicox SA Soci©t© anonyme with a registered capital of ‚ 50,299,694 Head Office: Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois “ 06410 BiotR.C.S. ANTIBES 403.942.642 On May 2nd,...
Press Release Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agentApril 24, 2024 “ release at 07:30 CET Sophia Antipolis,...
Press Release Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results Nicox Group revenue of ‚4.4 million (net revenue1 ‚3.9 million) for first quarter 2024Nicox Group cash of...
Dear Shareholder, The upcoming Extraordinary General Meeting, which will take place on April 10, is of particular importance for Nicox. I am writing to you today, in my capacity as the new Chief...
Nicox Updates on Corporate, Pipeline and Financing Perspectives
Nicox Announces Presentation of Data on NCX 470
Number of voting rights as of February 29, 2024
Layoffs are in store for employees at both Longeveron and Nicox, although neither company is spelling out how many staff will be affected.
Press Release Nicox Restructures Debt, Streamlines Operations to Extend Cash Runway and Focus Resources on NCX 470 Pivotal Trial Agreement in principle for an amendment to debt agreements for...
Press Release Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEO More than 25 years of experience in senior business development and corporate roles, with over 6 years as Chief...